X

Trial Profile

A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 05 Oct 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Conatumumab (Primary) ; Carboplatin; Paclitaxel
Indications Non-small cell lung cancer
Focus Adverse reactions; Therapeutic Use
Sponsors Amgen

Most Recent Events

29 Jan 2013 Results published in the Journal of Thoracic Oncology.
29 Jun 2012 Additional trial location added as reported by European Clinical Trials Database.
29 Jun 2012 Planned number of patients changed from 172 to 184 as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com